US5252334A
(en)
*
|
1989-09-08 |
1993-10-12 |
Cygnus Therapeutic Systems |
Solid matrix system for transdermal drug delivery
|
SE9003665D0
(sv)
*
|
1990-11-16 |
1990-11-16 |
Kabivitrum Ab |
Morphine prodrugs
|
WO1993014727A1
(en)
*
|
1992-01-31 |
1993-08-05 |
Cygnus Therapeutic Systems |
Transdermal administration of buprenorphine in the form of ion pair complexes
|
AU5551394A
(en)
*
|
1992-11-09 |
1994-06-08 |
Pharmetrix Corporation |
Combined analgesic delivery methods for pain management
|
US5883115A
(en)
*
|
1992-11-09 |
1999-03-16 |
Pharmetrix Division Technical Chemicals & Products, Inc. |
Transdermal delivery of the eutomer of a chiral drug
|
DE69333009T2
(de)
*
|
1992-11-09 |
2003-12-04 |
Neurogesx, Inc. |
Transdermale verabreichung von ketorolac
|
US5591767A
(en)
*
|
1993-01-25 |
1997-01-07 |
Pharmetrix Corporation |
Liquid reservoir transdermal patch for the administration of ketorolac
|
US5362566A
(en)
*
|
1993-03-04 |
1994-11-08 |
Minnesota Mining And Manufacturing Company |
Coating composition, granules coated with same, and method of reducing dust generation
|
WO1994022432A1
(en)
*
|
1993-04-07 |
1994-10-13 |
Rexham Industries Corp. |
Method of coating microporous membranes and resulting products
|
US5380760A
(en)
*
|
1993-11-19 |
1995-01-10 |
Minnesota Mining And Manufacturing Company |
Transdermal prostaglandin composition
|
US6190691B1
(en)
|
1994-04-12 |
2001-02-20 |
Adolor Corporation |
Methods for treating inflammatory conditions
|
US5962477A
(en)
*
|
1994-04-12 |
1999-10-05 |
Adolor Corporation |
Screening methods for cytokine inhibitors
|
US5552153A
(en)
*
|
1994-04-28 |
1996-09-03 |
Hoffman-La Roche Inc. |
Pharmaceutical composition for transdermal delivery
|
US5580574A
(en)
*
|
1994-04-28 |
1996-12-03 |
Hoffmann-La Roche Inc. |
Pharmaceutical composition for transdermal delivery
|
JP2819236B2
(ja)
*
|
1994-05-06 |
1998-10-30 |
日東電工株式会社 |
経皮吸収製剤
|
US5552406A
(en)
*
|
1994-06-17 |
1996-09-03 |
The Mclean Hospital Corporation |
Method for treating pain and brain perfusion abnormalities using mixed opioid agonist-antagonists
|
US5589480A
(en)
*
|
1994-08-17 |
1996-12-31 |
Elkhoury; George F. |
Topical application of opioid analgesic drugs such as morphine
|
DE4446600A1
(de)
*
|
1994-12-24 |
1996-06-27 |
Lohmann Therapie Syst Lts |
Transdermale Resorption von Wirkstoffen aus unterkühlten Schmelzen
|
US6344211B1
(en)
|
1994-12-24 |
2002-02-05 |
Lts Lohmann Therapie-Systeme Gmbh |
Transdermal absorption of active substances from subcooled melts
|
US5866143A
(en)
*
|
1995-03-24 |
1999-02-02 |
El Khoury And Stein, Ltd. |
Topical application of opioid drugs such as morphine for relief of itching and skin disease
|
US5990179A
(en)
*
|
1995-04-28 |
1999-11-23 |
Alza Corporation |
Composition and method of enhancing electrotransport agent delivery
|
US5985316A
(en)
*
|
1995-04-28 |
1999-11-16 |
Alza Corporation |
Composition and method of enhancing electrotransport agent delivery
|
US6573282B1
(en)
|
1995-09-12 |
2003-06-03 |
Adolor Corporation |
Peripherally active anti-hyperalgesic opiates
|
US5849761A
(en)
*
|
1995-09-12 |
1998-12-15 |
Regents Of The University Of California |
Peripherally active anti-hyperalgesic opiates
|
US5667799A
(en)
*
|
1995-10-30 |
1997-09-16 |
Caldwell; Larry J. |
Method for treating headache pain with topical local anesthetic compositions
|
US5733571A
(en)
*
|
1995-12-08 |
1998-03-31 |
Euro-Celtique, S.A. |
Transdermal patch for comparative evaluations
|
JPH1036265A
(ja)
|
1996-07-19 |
1998-02-10 |
Nitto Denko Corp |
ブプレノルフィン経皮吸収製剤
|
US5968547A
(en)
|
1997-02-24 |
1999-10-19 |
Euro-Celtique, S.A. |
Method of providing sustained analgesia with buprenorphine
|
US5919473A
(en)
*
|
1997-05-12 |
1999-07-06 |
Elkhoury; George F. |
Methods and devices for delivering opioid analgesics to wounds via a subdermal implant
|
DE19746191C2
(de)
|
1997-10-18 |
2000-05-18 |
Lohmann Therapie Syst Lts |
Verfahren zur Anwendung eines Wirkstoff enthaltenden Pflasters zur Bekämpfung oder Linderung einer Sucht
|
US6143278A
(en)
*
|
1998-02-23 |
2000-11-07 |
Elkhoury; George F. |
Topical application of opioid analgesic drugs such as morphine
|
US6011022A
(en)
*
|
1998-03-03 |
2000-01-04 |
El Khoury; George F. |
Topical application of muscarinic analgesic drugs such as neostigmine
|
US6103771A
(en)
*
|
1998-03-20 |
2000-08-15 |
Caldwell Galer Incorporated |
Method of treating neuroma pain
|
DE19814084B4
(de)
*
|
1998-03-30 |
2005-12-22 |
Lts Lohmann Therapie-Systeme Ag |
D2-Agonist enthaltendes transdermales therapeutisches System zur Behandlung des Parkinson-Syndroms und Verfahren zu seiner Herstellung
|
US5994330A
(en)
*
|
1998-11-09 |
1999-11-30 |
El Khoury; Georges F. |
Topical application of muscarinic agents such as neostigmine for treatment of acne and other inflammatory conditions
|
KR100383252B1
(ko)
*
|
1998-12-17 |
2003-07-16 |
주식회사 삼양사 |
부프레놀핀을함유하는경피투여조성물및이를포함하는패취
|
DE19901085C2
(de)
*
|
1999-01-14 |
2003-12-18 |
Lohmann Therapie Syst Lts |
Transdermales therapeutisches System mit einer selbstklebenden Matrix, enthaltend organische Säure-Additionssalze von Alkaloiden des Morphin- bzw. Morphinantyps
|
PL357158A1
(en)
|
2000-02-08 |
2004-07-12 |
Euro-Celtique, S.A. |
Controlled-release compositions containing opioid agonist and antagonist
|
DE10041478A1
(de)
|
2000-08-24 |
2002-03-14 |
Sanol Arznei Schwarz Gmbh |
Neue pharmazeutische Zusammensetzung
|
US20020119187A1
(en)
*
|
2000-09-29 |
2002-08-29 |
Cantor Adam S. |
Composition for the transdermal delivery of fentanyl
|
PT1381352E
(pt)
*
|
2001-03-16 |
2007-07-27 |
Alza Corp |
Adesivo transdérmico para administração de fenantil
|
US20050208117A1
(en)
*
|
2001-03-16 |
2005-09-22 |
Venkatraman Subramanian S |
Transdermal administration of fentanyl and analogs thereof
|
US8329734B2
(en)
*
|
2009-07-27 |
2012-12-11 |
Afgin Pharma Llc |
Topical therapy for migraine
|
DK1435945T3
(da)
*
|
2001-06-05 |
2008-12-01 |
Ronald Aung-Din |
Topisk migræne terapi
|
US20030068375A1
(en)
|
2001-08-06 |
2003-04-10 |
Curtis Wright |
Pharmaceutical formulation containing gelling agent
|
US20030044458A1
(en)
|
2001-08-06 |
2003-03-06 |
Curtis Wright |
Oral dosage form comprising a therapeutic agent and an adverse-effect agent
|
DE10141650C1
(de)
|
2001-08-24 |
2002-11-28 |
Lohmann Therapie Syst Lts |
Transdermales Therapeutisches System mit Fentanyl bzw. verwandten Substanzen
|
US20030181475A1
(en)
*
|
2002-03-20 |
2003-09-25 |
Euro-Celtique S.A. |
Method of administering buprenorphine to treat depression
|
WO2003101358A1
(en)
*
|
2002-05-31 |
2003-12-11 |
Titan Pharmaceuticals, Inc. |
Implantable polymeric device for sustained release of buprenorphine
|
JP4949625B2
(ja)
|
2002-06-10 |
2012-06-13 |
ユーロ−セルティーク エス.エイ. |
経皮送達デバイスに含有された活性薬剤の誤用を防止する、経皮送達デバイスの廃棄システム
|
US8246979B2
(en)
|
2002-07-30 |
2012-08-21 |
Ucb Pharma Gmbh |
Transdermal delivery system for the administration of rotigotine
|
DE10234673B4
(de)
*
|
2002-07-30 |
2007-08-16 |
Schwarz Pharma Ag |
Heißschmelz-TTS zur Verabreichung von Rotigotin und Verfahren zu seiner Herstellung sowie Verwendung von Rotigotin bei der Herstellung eines TTS im Heißschmelzverfahren
|
US8211462B2
(en)
*
|
2002-07-30 |
2012-07-03 |
Ucb Pharma Gmbh |
Hot-melt TTS for administering rotigotine
|
US8246980B2
(en)
*
|
2002-07-30 |
2012-08-21 |
Ucb Pharma Gmbh |
Transdermal delivery system
|
PT1530469E
(pt)
*
|
2002-08-20 |
2009-05-19 |
Euro Celtique Sa |
Forma de dosagem transdérmica que compreende um agente activo, um sal e uma forma de base livre de um antagonista
|
ATE444296T1
(de)
*
|
2002-10-25 |
2009-10-15 |
Euro Celtique Sa |
Analoga und prodrugs von buprenorphin
|
ES2239196T3
(es)
*
|
2002-12-02 |
2005-09-16 |
Schwarz Pharma Ag |
Suministro iontoforetico de rotigotina para el tratamiento de la enfermedad de parkinson.
|
MXPA05006334A
(es)
*
|
2002-12-13 |
2005-08-26 |
Euro Celtique Sa |
Dosis de buprenorfina transdermica para analgesia.
|
EP1913938A1
(en)
|
2002-12-13 |
2008-04-23 |
Euro-Celtique S.A. |
Transdermal buprenorphine dosage regimen for analgesia
|
US7413748B2
(en)
*
|
2002-12-13 |
2008-08-19 |
Purdue Pharma L.P. |
Transdermal buprenorphine to treat pain in sickle cell crisis
|
DE10261696A1
(de)
|
2002-12-30 |
2004-07-15 |
Schwarz Pharma Ag |
Vorrichtung zur transdermalen Verabreichung von Rotigotin-Base
|
DE602004031512D1
(de)
|
2003-03-31 |
2011-04-07 |
Titan Pharmaceuticals Inc |
Polymeres implantat zur verzögerten freisetzung von dopamin antagonisten
|
US20070065463A1
(en)
*
|
2003-06-20 |
2007-03-22 |
Ronald Aung-Din |
Topical therapy for the treatment of migranes, muscle sprains, muscle spasms, spasticity and related conditions
|
PT1638492E
(pt)
*
|
2003-07-25 |
2008-03-17 |
Euro Celtique Sa |
Tratamento pré-operatório da dor pós-operatória
|
US20080020028A1
(en)
*
|
2003-08-20 |
2008-01-24 |
Euro-Celtique S.A. |
Transdermal dosage form comprising an active agent and a salt and a free-base form of an adverse agent
|
ME02661B
(me)
|
2004-02-23 |
2017-06-20 |
Euro Celtique Sa |
Opioidni transdermalni preparat otporan na zloupotrebu
|
ES2653568T3
(es)
|
2004-06-12 |
2018-02-07 |
Collegium Pharmaceutical, Inc. |
Formulaciones de fármacos para la prevención del abuso
|
WO2006044206A2
(en)
*
|
2004-10-08 |
2006-04-27 |
Noven Pharmaceuticals, Inc. |
Transdermal drug delivery device including an occlusive backing
|
FR2879931B1
(fr)
*
|
2004-12-24 |
2007-03-30 |
Rhodia Chimie Sa |
Materiau silicone pour la liberation d'une molecule active
|
US20060223786A1
(en)
*
|
2005-04-01 |
2006-10-05 |
Smith David J |
Transdermal pain control method and device
|
TWI366460B
(en)
|
2005-06-16 |
2012-06-21 |
Euro Celtique Sa |
Cannabinoid active pharmaceutical ingredient for improved dosage forms
|
US8852638B2
(en)
|
2005-09-30 |
2014-10-07 |
Durect Corporation |
Sustained release small molecule drug formulation
|
WO2007061828A2
(en)
*
|
2005-11-21 |
2007-05-31 |
Schering-Plough Ltd. |
Pharmaceutical compositions comprising buprenorphine
|
US8518926B2
(en)
|
2006-04-10 |
2013-08-27 |
Knopp Neurosciences, Inc. |
Compositions and methods of using (R)-pramipexole
|
US20070248657A1
(en)
*
|
2006-04-25 |
2007-10-25 |
Smith David J |
Multi-compartment transdermal pain control device
|
AU2007253899A1
(en)
|
2006-05-16 |
2007-11-29 |
Knopp Neurosciences, Inc. |
Compositions of R(+) and S(-) pramipexole and methods of using the same
|
WO2008051889A1
(en)
|
2006-10-24 |
2008-05-02 |
The Johns Hopkins University |
Rapid release mini-tablets provide analgesia in laboratory animals
|
ES2388355T3
(es)
|
2006-11-03 |
2012-10-11 |
Durect Corporation |
Sistemas de suministro transdémico que comprenden bupivacaína
|
US8524695B2
(en)
|
2006-12-14 |
2013-09-03 |
Knopp Neurosciences, Inc. |
Modified release formulations of (6R)-4,5,6,7-tetrahydro-N6-propyl-2,6-benzothiazole-diamine and methods of using the same
|
RU2454409C2
(ru)
|
2007-03-14 |
2012-06-27 |
Нопп Ньюросайенсиз, Инк. |
Синтез хирально очищенных замещенных бензотиазолдиаминов
|
CN101801415B
(zh)
|
2007-05-25 |
2015-09-23 |
Rb医药品有限公司 |
利培酮化合物的持续递送制剂
|
CN101902996B
(zh)
*
|
2007-10-15 |
2014-11-26 |
阿尔扎公司 |
芬太尼的一天更换一次透皮施用
|
US8592424B2
(en)
|
2008-06-30 |
2013-11-26 |
Afgin Pharma Llc |
Topical regional neuro-affective therapy
|
CA2734491A1
(en)
|
2008-08-19 |
2010-02-25 |
Knopp Neurosciences, Inc. |
Compositions and methods of using (r)-pramipexole
|
US20100221313A1
(en)
*
|
2008-12-01 |
2010-09-02 |
Innovative Pharmaceuticals, Llc |
Transdermal reservoir patch
|
US10668060B2
(en)
|
2009-12-10 |
2020-06-02 |
Collegium Pharmaceutical, Inc. |
Tamper-resistant pharmaceutical compositions of opioids and other drugs
|
EP2366388A1
(de)
|
2010-03-17 |
2011-09-21 |
Ratiopharm GmbH |
Nicht-okklusives transdermales therapeutisches System zur Verabreichung von Buprenorphin
|
WO2011130455A1
(en)
|
2010-04-13 |
2011-10-20 |
Najib Babul |
Dermal pharmaceutical compositions of 1-methyl-2',6'-pipecoloxylidide and method of use
|
GB2481017B
(en)
|
2010-06-08 |
2015-01-07 |
Rb Pharmaceuticals Ltd |
Microparticle buprenorphine suspension
|
US9272044B2
(en)
|
2010-06-08 |
2016-03-01 |
Indivior Uk Limited |
Injectable flowable composition buprenorphine
|
MY166034A
(en)
|
2010-12-22 |
2018-05-21 |
Purdue Pharma Lp |
Encased tamper resistant controlled release dosage forms
|
JP5638151B2
(ja)
|
2010-12-23 |
2014-12-10 |
パーデュー、ファーマ、リミテッド、パートナーシップ |
不正加工抵抗性の(tamperresistant)固形経口剤形
|
DE102011076653A1
(de)
|
2011-05-27 |
2012-11-29 |
Acino Ag |
Transdermales therapeutisches System enthaltend Buprenorphin und eine alpha-Hydroxysäure
|
DK2706986T3
(en)
|
2011-09-19 |
2015-06-01 |
Orexo Ab |
NEW ADDICTION PREVENTING PHARMACEUTICAL COMPOSITION FOR TREATMENT OF OPIOID ADDICTION
|
JP6289378B2
(ja)
|
2011-12-12 |
2018-03-07 |
エルテーエス ローマン テラピー−ジステーメ アーゲー |
ブプレノルフィンを含む経皮送達システム
|
WO2013096816A1
(en)
|
2011-12-22 |
2013-06-27 |
Biogen Idec Ma Inc. |
Improved synthesis of amine substituted 4,5,6,7-tetrahydrobenzothiazole compounds
|
US11547676B2
(en)
|
2012-12-28 |
2023-01-10 |
Teikoku Seiyaku Co., Ltd. |
Extended buprenorphine transdermal delivery compositions and methods for using the same
|
US9149533B2
(en)
|
2013-02-05 |
2015-10-06 |
Purdue Pharma L.P. |
Tamper resistant pharmaceutical formulations
|
US9662313B2
(en)
|
2013-02-28 |
2017-05-30 |
Knopp Biosciences Llc |
Compositions and methods for treating amyotrophic lateral sclerosis in responders
|
US10751287B2
(en)
|
2013-03-15 |
2020-08-25 |
Purdue Pharma L.P. |
Tamper resistant pharmaceutical formulations
|
MA38698B1
(fr)
|
2013-06-04 |
2017-10-31 |
Lts Lohmann Therapie Systeme Ag |
Système d'administration transdermique
|
US9468630B2
(en)
|
2013-07-12 |
2016-10-18 |
Knopp Biosciences Llc |
Compositions and methods for treating conditions related to increased eosinophils
|
CN105764507B
(zh)
|
2013-07-12 |
2019-07-19 |
诺普生物科学有限责任公司 |
治疗升高的嗜酸性粒细胞和/或嗜碱性粒细胞的水平
|
AU2014306683B2
(en)
|
2013-08-13 |
2017-10-12 |
Knopp Biosciences Llc |
Compositions and methods for treating plasma cell disorders and B-cell prolymphocytic disorders
|
ES2871556T3
(es)
|
2013-08-13 |
2021-10-29 |
Knopp Biosciences Llc |
Composiciones y métodos para el tratamiento de la urticaria crónica
|
GB201404139D0
(en)
*
|
2014-03-10 |
2014-04-23 |
Rb Pharmaceuticals Ltd |
Sustained release buprenorphine solution formulations
|
DE102014013448A1
(de)
|
2014-09-16 |
2016-03-17 |
Alfred E. Tiefenbacher (Gmbh & Co. Kg) |
Transdermales Therapeutisches System umfassend Buprenorphin
|
ES2808150T3
(es)
|
2014-11-07 |
2021-02-25 |
Indivior Uk Ltd |
Regímenes de dosificación de buprenorfina
|
US9656441B2
(en)
|
2015-01-08 |
2017-05-23 |
Alfred E. Tiefenbacher ( Gmbh & Co. Kg) |
Transdermal patch
|
US10383816B2
(en)
|
2015-03-02 |
2019-08-20 |
Afgin Pharma, Llc |
Topical regional neuro-affective therapy with cannabinoid combination products
|
US20160256410A1
(en)
|
2015-03-02 |
2016-09-08 |
Afgin Pharma, Llc |
Topical regional neuro-affective therapy in mammals with cannabinoids
|
EP3349737A4
(en)
*
|
2015-09-14 |
2019-05-15 |
Amneal Pharmaceuticals LLC |
SYSTEM FOR TRANSDERING
|
WO2017222575A1
(en)
|
2016-06-23 |
2017-12-28 |
Collegium Pharmaceutical, Inc. |
Process of making more stable abuse-deterrent oral formulations
|
US20180049994A1
(en)
|
2016-08-16 |
2018-02-22 |
Afgin Pharma, Llc |
Topical regional neuro-affective therapy with caryophyllene
|
WO2018064544A1
(en)
|
2016-09-29 |
2018-04-05 |
Gesea Biosciences Inc. |
Bioerodible contraceptive implant and methods of use thereof
|
US10646484B2
(en)
|
2017-06-16 |
2020-05-12 |
Indivior Uk Limited |
Methods to treat opioid use disorder
|
AU2019396627A1
(en)
*
|
2018-12-14 |
2021-07-15 |
Harvest Bio Llc |
A digital therapeutic component to optimize induction of buprenorphine-containing products
|
US12090151B1
(en)
|
2023-05-12 |
2024-09-17 |
Michael Guarnieri |
Injectable sustained release buprenorphine formulation
|